BMEA - Company ID 0001840439
The table below shows Biomea Fusion, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$11.67M | -$25.67M | -$32.03M | -$24.04M | -$9.99M | -$4.08M |
| Capital expenditure | - | $0.00 | $35.00K | $2.91M | $95.00K | $67.00K |
| Investing cash flow | $550.00K | $0.00 | -$35.00K | -$1.76M | $20.44M | -$38.51M |
| Dividends paid | - | - | - |
Biomea Fusion, Inc. reported operating cash flow of -$70.37M for fiscal year 2025. That is up 41.3% from -$119.89M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$1.28M (FY 2019) to -$70.37M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | - | $3.25M | $116.00K | $201.00K | $31.00K | -$3.00K |